NCT00161590View on ClinicalTrials.gov

Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2004

Conditions
T-Cell LymphomaLymphoma, Non-Hodgkin's
Interventions
DRUG

CHOP and alemtuzumab

Trial Locations (1)

10021

Weill Medical College of Cornell University, New York

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER